These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22430922)

  • 21. Formulation of microemulsion systems for dermal delivery of silymarin.
    Panapisal V; Charoensri S; Tantituvanont A
    AAPS PharmSciTech; 2012 Jun; 13(2):389-99. PubMed ID: 22350738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
    Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
    Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of triacetin effect on indomethacin release from poly(methyl methacrylate) microspheres: evaluation of interactions using FT-IR and NMR spectroscopies.
    Yuksel N; Baykara M; Shirinzade H; Suzen S
    Int J Pharm; 2011 Feb; 404(1-2):102-9. PubMed ID: 21093553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on in vitro release behaviour of indomethacin-loaded polystyrene microparticles.
    Tamilvanan S; Sa B
    Int J Pharm; 2000 May; 201(2):187-97. PubMed ID: 10878325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of matrix type mucoadhesive tablets containing indomethacin for buccal application.
    Ikeuchi-Takahashi Y; Sasatsu M; Onishi H
    Int J Pharm; 2013 Sep; 453(2):454-61. PubMed ID: 23791737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combinational supercritical CO2 system for nanoparticle preparation of indomethacin.
    Tozuka Y; Miyazaki Y; Takeuchi H
    Int J Pharm; 2010 Feb; 386(1-2):243-8. PubMed ID: 19895877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation of indomethacin-nicotinamide cocrystal formation induced by thermal stress in the solid or liquid state.
    Lin HL; Zhang GC; Huang YT; Lin SY
    J Pharm Sci; 2014 Aug; 103(8):2386-95. PubMed ID: 24942554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physicochemical characterisation of a novel thermogelling formulation for percutaneous penetration of 5-aminolevulinic acid.
    Grüning N; Müller-Goymann CC
    J Pharm Sci; 2008 Jun; 97(6):2311-23. PubMed ID: 17828744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation of two-drug controlled release non-biodegradable microparticles for potential treatment of muscles pain and spasm and their simultaneous spectrophotometeric estimation.
    Khan SA; Ahmad M; Murtaza G; Aamir MN; Akhtar N; Kousar R
    Acta Pol Pharm; 2010; 67(3):299-306. PubMed ID: 20524433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentapeptide modified ethosomes for enhanced skin retention and topical efficacy activity of indomethacin.
    Niu J; Yuan M; Li H; Liu Y; Wang L; Fan Y; Zhang Y; Liu X; Li L; Zhang J; Zhao C
    Drug Deliv; 2022 Dec; 29(1):1800-1810. PubMed ID: 35656937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salt formation during freeze-drying--an approach to enhance indomethacin dissolution.
    Thakral S; Suryanarayanan R
    Pharm Res; 2015 Nov; 32(11):3722-31. PubMed ID: 26063046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation, characterization and pharmacokinetics of liposomes-encapsulated cyclodextrins inclusion complexes for hydrophobic drugs.
    Chen H; Gao J; Wang F; Liang W
    Drug Deliv; 2007 Apr; 14(4):201-8. PubMed ID: 17497352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
    Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
    Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing and characterizing of tramadol hydrochloride transdermal patches prepared with Ficus carica fruit mucilage and povidone.
    Ahad HA; Ishaq BM; Shaik M; Bandagisa F
    Pak J Pharm Sci; 2016 May; 29(3):945-51. PubMed ID: 27166538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of branched cationic beta-cyclodextrin polymer/indomethacin complex and its release profile from alginate hydrogel.
    Xin J; Guo Z; Chen X; Jiang W; Li J; Li M
    Int J Pharm; 2010 Feb; 386(1-2):221-8. PubMed ID: 19945520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancy.
    Hu Y; Zhi Z; Wang T; Jiang T; Wang S
    Eur J Pharm Biopharm; 2011 Nov; 79(3):544-51. PubMed ID: 21767643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanocolloids of indomethacin prepared using sonication and subsequent encapsulation with polysaccharide films.
    Milkova V; Kamburova K; Radeva T
    Colloids Surf B Biointerfaces; 2013 Aug; 108():279-84. PubMed ID: 23563295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and in-vitro evaluation of floating microballoons of indomethacin.
    Bhardwaj P; Chaurasia H; Chaurasia D; Prajapati SK; Singh S
    Acta Pol Pharm; 2010; 67(3):291-8. PubMed ID: 20524432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
    Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
    Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.